Skip to main content

Advertisement

SpringerLink
Log in

Alkaline phosphatase inhibition by levamisole prevents 1,25-dihydroxyvitamin D3-stimulated bone mineralization in the mouse

  • Laboratory Investigations
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Summary

To determine the relationship between alkaline phosphatase (AP), 1,25(OD)2D3 and bone formationin vivo, we have examined the effects of levamisole, a stereospecific inhibitor of AP on bone formation and on 1,25(OH)2D3-stimulated bone mineralization in the mouse. Normal mice were injected daily with levamisole at doses of 40 and 80 mg/kg/b.w. The compound was given alone or in combination with 1,25(OH)2D3 infusion (0.05 μg/kg/d) for 7 days. Treatment with levamisole alone inhibited the serum AP activity (mainly of skeletal origin in mice) by 18.4 and 61.3% for the low and high dose respectively. No deleterious effect on body growth, tibia length, and bone cells population was detected. The moderate inhibition of AP activity produced by the lower dose of levamisole alone (18.4%) or in combination with 1,25(OH)2D3 (37.9%) was associated with a reduced endosteal matrix apposition rate (MaAR) determined by double3H-proline labeling method. This effect was related to a levamisole-induced fall in serum phosphate. Despite the moderate inhibition of AP activity, the mineral apposition rate (MiAR) determined by the double tetracycline labeling method remained normal. Moreover, 1,25(OH)2D3 infusion still resulted in increased MiAR which was stimulated to the same extent as in the absence of levamisole. By contrast, the more severe inhibition of AP activity induced by 80 mg/kg of levamisole alone (61.3%) or in combination with 1,25(OH)2D3 (45.8%) inhibited both the MaAR and the MiAR and prevented the stimulatory effect of 1,25(OH)2D3 on bone mineralization. The data show that AP activity affects the bone matrix and mineral apposition ratesin vivo and that severe inhibition of AP activity inhibits the 1,25(OH)2D3-induced stimulation of bone mineralization in the mouse.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Whyte MP (1983) Alkaline phosphatase and the measurement of bone formation. In: Frame B, Potts JT (eds) Clinical disorders of bone and mineral metabolism. Excerpta Medica, Amsterdam, Oxford, Princeton, pp 120–124

    Google Scholar 

  2. Robison R (1923) The possible significance of hexosephosphoric esters in ossification. Part I. Biochem J 17:268–293

    Google Scholar 

  3. Ali SY, Sajdera SW, Anderson HC (1970) Isolation and characterization of calcifying matrix vesicles from epiphyseal cartilage. Proc Natl Acad Sci 67:1513–1520

    Article  PubMed  CAS  Google Scholar 

  4. Van Belle H (1976) Alkaline phosphatase. I-kinetics and inhibition by levamisole of purified isoenzymes from humans. Clin Chem 22:972–976

    PubMed  Google Scholar 

  5. Thomas MC, Ramp WK (1979) Effects of parathyroid hormone on alkaline phosphatase activity and mineralization of cultured chick embryo tibia. Calcif Tissue Int 27:137–142

    Article  PubMed  CAS  Google Scholar 

  6. Nijweide PJ, Kawilarang De Haas EWM, Wassenaar AM (1981) Alkaline phosphatase and calcification, correlated or not? Metab Bone Dis Rel Res 3:61–66

    Article  CAS  Google Scholar 

  7. Fallon M, Whyte M, Teitelbaum S (1980) Stereospecific inhibition of alkaline phosphatase by levamisole prevents in vitro calcification of rachitic rat cartilage. Lab Invest 43:489–494

    PubMed  CAS  Google Scholar 

  8. Farley JR, Puzas JE, Baylink DJ (1982) Effect of skeletal alkaline phosphatase inhibitors on bone cell proliferation in vitro. Mineral Electrolyte Metab 7:316–323

    CAS  Google Scholar 

  9. Manolagas SC, Burton DW, Deftos LJ (1981) 1,25-dihydroxyvitamin D3 stimulates the alkaline phosphatase activity of osteoblast-like cells. Biol Chem 256:7115–7117

    CAS  Google Scholar 

  10. Mulkino MA, Manolagas SC, Deftos LJ, Sussman HH (1983) 1,25-Dihydroxyvitamin D3 increases bone alkaline phosphatase isoenzyme levels in human osteogenic sarcoma cells. J Biol Chem 258:6219–6225

    Google Scholar 

  11. Kumegawa M, Ikeda E, Tanaka S, Haneji T, Yora T, Sakagishi Y, Minami N, Hiramatsu M (1984) The effects of prostaglandin E2, parathyroid hormone, 1,25-dihydroxycholecalciferol and cyclic nucleotide analogs on alkaline phosphatase activity in osteoblastic cells. Calcif Tissue Int 36:72–76

    Article  PubMed  CAS  Google Scholar 

  12. Majeska RJ, Rodan GA (1982) The effect of 1,25(OH)2D3 on alkaline phosphatase in osteoblastic osteosarcoma cells. J Biol Chem 257:3362–3365

    PubMed  CAS  Google Scholar 

  13. Borgers M (1973) The cytochemical application of new potent inhibitors of alkaline phosphatase. J Histochem Cytochem 21:812–824

    PubMed  CAS  Google Scholar 

  14. Marie PJ, Travers R (1983) Continuous infusion of 1,25-dihydroxyvitamin D3 stimulates bone turnover in the normal young mouse. Calcif Tissue Int 35:418–425

    Article  PubMed  CAS  Google Scholar 

  15. Marie PJ, Hott M, Garba MT (1985) Contrasting effects of 1,25 dihydroxyvitamin D3 on bone and mineral appositional rates in the mouse. Metabolism 34:777–783

    Article  PubMed  CAS  Google Scholar 

  16. Shepard RM, Deluca HF (1980) In: Cormic DB, Wright LD (eds) Methods in enzymology: determination of vitamin D and its metabolites in plasma. Academic Press, New York pp 393–414

    Google Scholar 

  17. Menahan LA, Sobocinski KA, Austin BP (1984) The origin of plasma alkaline phosphatase activity in mice and rats. Comp Biochem Physiol 79B:279–283

    CAS  Google Scholar 

  18. Marie PJ (1982) Dissertation thesis, University of Paris VI, Paris

    Google Scholar 

  19. Borgers M, Thone F (1975) The inhibition of alkaline phosphatase by L.p- bromotetramisole. Histochemistry 44:277–280

    Article  PubMed  CAS  Google Scholar 

  20. Rasmussen H (1983) Hypophosphatasia. In: Stanbury JB, Wingaarden JB, Frederickson DS, Goldstein JL, Brown MS (eds) The metabolic basis of inherited disease, 5th ed. McGraw-Hill, New York, pp 1497–1507

    Google Scholar 

  21. Lerner V, Granstrom G (1984) Effect of levamisole on bone resorption in cultured mouse calvaria. Eur J Pharmacol 105:1–14

    Article  PubMed  CAS  Google Scholar 

  22. Wong GL, Luben RA, Cohn DV (1977) 1,25 Dihydroxycholecalciferol and parathormone: effects on isolated osteoclast-like and osteoblast-like cells. Science 197:663–665

    Article  PubMed  CAS  Google Scholar 

  23. Canalis EM (1983) Effect of hormones and growth factors on alkaline phosphatase activity and collagen synthesis in cultured rat calvariae. Metabolism 32:14–20

    Article  PubMed  CAS  Google Scholar 

  24. Haneji T, Kurihara N, Ikeda K, Kumegawa M (1983) 1α,25-Dihydroxyvitamin D3 and analogues of vitamin D3 induce alkaline phosphatase activity in osteoblastic cells derived from newborn mouse calvaria. J Biochem 94:1127–1132

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Unité 18 INSERM-Hôpital Lariboisière, 6 rue Guy Patin, 75010, Paris, France

    Marie-Thérèse Garba & Pierre J. Marie

Authors
  1. Marie-Thérèse Garba
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pierre J. Marie
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Garba, MT., Marie, P.J. Alkaline phosphatase inhibition by levamisole prevents 1,25-dihydroxyvitamin D3-stimulated bone mineralization in the mouse. Calcif Tissue Int 38, 296–302 (1986). https://doi.org/10.1007/BF02556610

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02556610

Key words

Search

Navigation